Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities VRDN - Viridian Therapeutics, Inc.
-94.3 M
LAST VALUE
-12.64%
2 YEAR CAGR
-25.81%
5 YEAR CAGR
-164.22%
10 YEAR CAGR